Sangmi Jeong
Overview
Explore the profile of Sangmi Jeong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
0
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeong S, Tollison T, Brochu H, Chou H, Yu T, Baghaie P, et al.
BMC Infect Dis
. 2025 Mar;
25(1):349.
PMID: 40075274
Background: Performance of a 16S rRNA analysis of the cervicovaginal microbiome of 220 participants recruited into the T Cell Response against Chlamydia (TRAC) cohort between February 2011 and August 2014...
2.
Jeong S, Tollison T, Brochu H, Chou H, Huntress I, Yount K, et al.
bioRxiv
. 2024 Dec;
PMID: 39651251
Introduction: Chlamydia trachomatis (CT) infection can lead to pelvic inflammatory disease, infertility and other reproductive sequelae when it ascends to the upper genital tract. Factors including chlamydial burden, co-infection with...
3.
Jeong S, Tollison T, Brochu H, Chou H, Yu T, Baghaie P, et al.
medRxiv
. 2024 Nov;
PMID: 39606371
Background: Performance of a 16S rRNA analysis of the cervicovaginal microbiome of 220 participants recruited into the T Cell Response against Chlamydia (TRAC) cohort between February 2011 and August 2014...
4.
Brochu H, Smith E, Jeong S, Carlson M, Hansen S, Tisoncik-Go J, et al.
Microbiol Spectr
. 2024 Sep;
12(11):e0128524.
PMID: 39345211
Rhesus cytomegalovirus expressing simian immunodeficiency virus (RhCMV/SIV) vaccines protect ~59% of vaccinated rhesus macaques against repeated limiting-dose intra-rectal exposure with highly pathogenic SIVmac239M, but the exact mechanism responsible for the...
5.
Brochu H, Smith E, Jeong S, Carlson M, Hansen S, Tisoncik-Go J, et al.
bioRxiv
. 2024 Mar;
PMID: 38464179
Background: RhCMV/SIV vaccines protect ∼59% of vaccinated rhesus macaques against repeated limiting-dose intra-rectal exposure with highly pathogenic SIVmac239M, but the exact mechanism responsible for the vaccine efficacy is not known....